Viridian Therapeutics, Inc. VRDN D&A

D&A at other companies

AmgenAMGN

$1.11B-17.1%

Immunovant, Inc.IMVT

$96K-11.9%

Vera TherapeuticsVERA

$140K+64.7%

RegenxbioRGNX

$3.76M-3.8%

Zevra Therapeutics, Inc.ZVRA

$364K-78.0%

Shattuck Labs, Inc.STTK

$891K-4.8%

FAQ

What is Viridian Therapeutics, Inc.'s D&A?

Viridian Therapeutics, Inc. (VRDN) reported D&A of $117K in Q2 2026.

How has Viridian Therapeutics, Inc.'s D&A changed year-over-year?

Viridian Therapeutics, Inc.'s D&A increased by 3.5% year-over-year, from $113K to $117K.

What is the long-term trend for Viridian Therapeutics, Inc.'s D&A?

Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s D&A has grown at a 39.9% compound annual growth rate (CAGR), from $120K to $460K.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.